Restoration of the gut microbiome after delivery by caesarean section to prevent asthma

This project aims to identify factors that restore gut microbiome health in children born via caesarean section to mitigate their increased asthma risk, potentially leading to novel prevention strategies.

Subsidie
€ 1.999.934
2024

Projectdetails

Introduction

Associations between caesarean section (CS) and childhood asthma may be mediated through microbial changes. In 700 children followed prospectively from birth, I recently showed that microbial perturbations after delivery by CS explain the delivery mode-associated risk of developing asthma in the first 6 years of life.

Risk Factors

CS was associated with more than a doubled risk of later asthma and allergic sensitization as well as immense compositional changes in the gut microbiota. An increased asthma risk was only found in children born by caesarean section if their microbiome did not normalize by age 1 year, suggesting that a healthy microbial maturation can alleviate the child’s increased asthma risk.

Project Hypothesis

Under the hypothesis that asthma risk from CS can be avoided by restoring the early gut microbiome, the proposed project will:

  1. Identify key environmental, dietary, and host factors that help restore a CS-perturbed microbiome.
  2. Map the compositional and functional potential of the CS microbial profiles.
  3. Evaluate the role of the virome in the CS associations.
  4. Perform co-cultures of key microbial consortia that may restore a healthy trajectory.

Experimental Validation

Finally, I will perform murine experimental models to validate the findings and conduct pilot studies on CS microbiota restoration by fecal microbiota transplantation (FMT) and fecal virome transplantation (FVT) in newborns.

Research Impact

This will be a truly translational research project, with the potential to go from clinical observations to mechanisms based on bioinformatics, microbiological laboratory work, experimental models, and a pilot human trial to infer causal relationships with the perspective of developing a potential future intervention strategy.

Future Directions

If successful, this strategy will be groundbreaking for understanding the microbiome’s role in asthma development after CS and may potentially lead to novel prevention strategies and targeted, efficient microbiota manipulation in children with early microbial perturbations.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.999.934
Totale projectbegroting€ 1.999.934

Tijdlijn

Startdatum1-5-2024
Einddatum30-4-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • REGION HOVEDSTADENpenvoerder

Land(en)

Denmark

Vergelijkbare projecten binnen European Research Council

ERC Advanced...

Microbiome-derived asthma and allergy protective substances for prevention

The APROSUS Project aims to characterize microbiome-derived agents to understand their protective properties against asthma and allergies, paving the way for innovative prevention strategies.

€ 2.500.000
ERC Consolid...

Role of prenatal stress-induced fetal neuro-immune rewiring in susceptibility to develop pediatric eczema

This project investigates how prenatal stress influences the development of eczema in infants using mouse models and advanced imaging techniques to identify neuro-immune dysregulations.

€ 2.857.135
ERC Starting...

Microbial ecosystems biology in the human gut

This project aims to develop a comprehensive ecosystem model of child gut microbiota using multiomic data to predict and manipulate microbial responses for improved health interventions.

€ 1.485.413
ERC Proof of...

Postbiotic Restoration Of the Metabolome Of Moms

PRO-MOM aims to develop a postbiotic supplement to restore maternal-neonatal microbiota and mitigate behavioral disturbances in offspring following antibiotic use during pregnancy and breastfeeding.

€ 150.000
ERC Starting...

Deciphering the antibody-microbiota axis in early life

This project aims to explore how early life immune exposures shape immunoglobulin repertoires and their impact on health, particularly allergies, by analyzing B cell receptor sequences and microbiota antigens.

€ 1.650.000